Concepts (102)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Liver Transplantation | 4 | 2004 | 215 | 0.420 |
Why?
|
| Granuloma | 3 | 2004 | 41 | 0.300 |
Why?
|
| Common Bile Duct Diseases | 2 | 2004 | 10 | 0.250 |
Why?
|
| Common Bile Duct | 1 | 2003 | 19 | 0.200 |
Why?
|
| Ampulla of Vater | 1 | 2003 | 12 | 0.200 |
Why?
|
| Pancreatic Diseases | 1 | 2003 | 38 | 0.200 |
Why?
|
| Amyloidosis | 1 | 2003 | 66 | 0.190 |
Why?
|
| Immunocompromised Host | 1 | 2003 | 108 | 0.190 |
Why?
|
| Liver Diseases | 2 | 2004 | 155 | 0.190 |
Why?
|
| Liver Cirrhosis, Alcoholic | 1 | 2002 | 19 | 0.190 |
Why?
|
| Liver Failure | 1 | 2002 | 18 | 0.190 |
Why?
|
| Lung Diseases | 1 | 2003 | 183 | 0.180 |
Why?
|
| Adenocarcinoma | 1 | 2024 | 350 | 0.170 |
Why?
|
| Hepatitis C | 1 | 2002 | 149 | 0.160 |
Why?
|
| Inflammation | 2 | 2004 | 1147 | 0.160 |
Why?
|
| Laparoscopy | 1 | 2024 | 494 | 0.150 |
Why?
|
| Parotid Neoplasms | 1 | 2016 | 4 | 0.130 |
Why?
|
| Diagnosis, Differential | 5 | 2016 | 981 | 0.130 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2016 | 8 | 0.130 |
Why?
|
| Carcinoma | 1 | 2016 | 124 | 0.120 |
Why?
|
| Cholangitis, Sclerosing | 2 | 2004 | 13 | 0.110 |
Why?
|
| Postoperative Complications | 3 | 2004 | 1314 | 0.090 |
Why?
|
| Guanylate Cyclase | 1 | 2011 | 10 | 0.090 |
Why?
|
| Receptors, Guanylate Cyclase-Coupled | 1 | 2011 | 6 | 0.090 |
Why?
|
| Receptors, Peptide | 1 | 2011 | 34 | 0.090 |
Why?
|
| Lymph Nodes | 1 | 2011 | 227 | 0.080 |
Why?
|
| Colonic Neoplasms | 1 | 2011 | 222 | 0.080 |
Why?
|
| Middle Aged | 7 | 2024 | 17702 | 0.080 |
Why?
|
| Liver | 2 | 2004 | 860 | 0.080 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2011 | 347 | 0.080 |
Why?
|
| Neoplasm Staging | 2 | 2024 | 518 | 0.070 |
Why?
|
| Breath Tests | 1 | 2007 | 14 | 0.070 |
Why?
|
| Urease | 1 | 2007 | 9 | 0.070 |
Why?
|
| Colony Count, Microbial | 1 | 2007 | 59 | 0.060 |
Why?
|
| Helicobacter Infections | 1 | 2007 | 55 | 0.060 |
Why?
|
| Helicobacter pylori | 1 | 2007 | 58 | 0.060 |
Why?
|
| Endoscopy, Gastrointestinal | 1 | 2007 | 73 | 0.060 |
Why?
|
| Survival Rate | 2 | 2011 | 853 | 0.060 |
Why?
|
| Female | 7 | 2024 | 33000 | 0.060 |
Why?
|
| Aged | 5 | 2024 | 14512 | 0.050 |
Why?
|
| Survival Analysis | 2 | 2003 | 586 | 0.050 |
Why?
|
| Xanthomatosis | 1 | 2004 | 8 | 0.050 |
Why?
|
| Peritoneal Neoplasms | 1 | 2024 | 28 | 0.050 |
Why?
|
| Cholangiocarcinoma | 1 | 2004 | 31 | 0.050 |
Why?
|
| Gastrointestinal Neoplasms | 1 | 2024 | 33 | 0.050 |
Why?
|
| Surgery, Computer-Assisted | 1 | 2024 | 59 | 0.050 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2003 | 5 | 0.050 |
Why?
|
| Male | 6 | 2024 | 29988 | 0.050 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2003 | 19 | 0.050 |
Why?
|
| Humans | 11 | 2024 | 63608 | 0.050 |
Why?
|
| Fibrosis | 1 | 2003 | 160 | 0.050 |
Why?
|
| Hepatitis C Antibodies | 1 | 2002 | 9 | 0.050 |
Why?
|
| Graft Rejection | 1 | 2003 | 300 | 0.050 |
Why?
|
| Atherectomy, Coronary | 1 | 2002 | 12 | 0.050 |
Why?
|
| Catheters, Indwelling | 1 | 2002 | 69 | 0.040 |
Why?
|
| Coronary Angiography | 1 | 2002 | 206 | 0.040 |
Why?
|
| Polymerase Chain Reaction | 1 | 2002 | 517 | 0.040 |
Why?
|
| Hepacivirus | 1 | 2002 | 139 | 0.040 |
Why?
|
| RNA, Viral | 1 | 2002 | 276 | 0.040 |
Why?
|
| Liver Neoplasms | 1 | 2003 | 300 | 0.040 |
Why?
|
| Pancreatic Neoplasms | 1 | 2003 | 343 | 0.040 |
Why?
|
| Thrombectomy | 1 | 2002 | 240 | 0.040 |
Why?
|
| Lung Neoplasms | 1 | 2003 | 684 | 0.030 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2016 | 67 | 0.030 |
Why?
|
| Adult | 4 | 2011 | 16894 | 0.030 |
Why?
|
| Epithelial Cells | 1 | 2016 | 392 | 0.030 |
Why?
|
| Reoperation | 2 | 2004 | 294 | 0.020 |
Why?
|
| Prospective Studies | 2 | 2011 | 3304 | 0.020 |
Why?
|
| Receptors, Enterotoxin | 1 | 2011 | 6 | 0.020 |
Why?
|
| Lymphatic Metastasis | 1 | 2011 | 92 | 0.020 |
Why?
|
| Recurrence | 2 | 2003 | 642 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2011 | 542 | 0.020 |
Why?
|
| Treatment Outcome | 3 | 2004 | 5703 | 0.020 |
Why?
|
| Duodenoscopy | 1 | 2007 | 3 | 0.020 |
Why?
|
| Gastroscopy | 1 | 2007 | 23 | 0.020 |
Why?
|
| Duodenum | 1 | 2007 | 42 | 0.020 |
Why?
|
| Carbon Dioxide | 1 | 2007 | 86 | 0.020 |
Why?
|
| Stomach | 1 | 2007 | 88 | 0.020 |
Why?
|
| Prognosis | 1 | 2011 | 1748 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2007 | 181 | 0.020 |
Why?
|
| Retrospective Studies | 2 | 2011 | 6694 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2011 | 2464 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2011 | 1536 | 0.010 |
Why?
|
| Hepatitis, Autoimmune | 1 | 2003 | 5 | 0.010 |
Why?
|
| Graft Survival | 1 | 2004 | 295 | 0.010 |
Why?
|
| South America | 1 | 2002 | 26 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2007 | 1667 | 0.010 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2003 | 102 | 0.010 |
Why?
|
| Coronary Thrombosis | 1 | 2002 | 21 | 0.010 |
Why?
|
| Videotape Recording | 1 | 2002 | 46 | 0.010 |
Why?
|
| Liver Cirrhosis | 1 | 2003 | 173 | 0.010 |
Why?
|
| Ischemia | 1 | 2003 | 205 | 0.010 |
Why?
|
| Europe | 1 | 2002 | 197 | 0.010 |
Why?
|
| Saphenous Vein | 1 | 2002 | 52 | 0.010 |
Why?
|
| Coronary Stenosis | 1 | 2002 | 39 | 0.010 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 5496 | 0.010 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2002 | 168 | 0.010 |
Why?
|
| Equipment Design | 1 | 2002 | 358 | 0.010 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2002 | 225 | 0.010 |
Why?
|
| Time Factors | 1 | 2007 | 3768 | 0.010 |
Why?
|
| Incidence | 1 | 2002 | 1384 | 0.010 |
Why?
|
| Stents | 1 | 2002 | 506 | 0.010 |
Why?
|